Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HAVN Life Sciences Inc C.HAVN

Alternate Symbol(s):  HAVLF

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. The Company has two business divisions: HAVN Labs and HAVN Retail. The HAVN Labs division is engaged in the development of research protocols to cover the production of Psilocybe spp. Through its research division, HAVN Labs, it has developed an end-to-end supply chain of GMP naturally derived psychedelic compounds for research. The HAVN Retail division formulates and sells natural health products (NHPs) using compounds. It offers a full range of mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.


CSE:HAVN - Post by User

Post by Idvhmz123on Mar 01, 2021 7:34pm
166 Views
Post# 32691600

HAVN information webcast Mar 3rd

HAVN information webcast Mar 3rdHAVN Life to host investor webcast March 3 2021-02-26 09:30 ET - News Release Mr. Tim Moore reports HAVN LIFE SCIENCES TO HOST INVESTOR WEBCAST ON MARCH 3, 2021 HAVN Life Sciences Inc. will host a webcast investor presentation on Wednesday, March 3, at 2 p.m. EST (11 a.m. PST). During the webcast, chief executive officer Tim Moore will lead a PowerPoint presentation that will cover key areas of HAVN Life's business plan. He'll be outlining the company's road map for 2021, sharing significant updates on HAVN Labs and HAVN Retail, discussing the launch of the retail product line this year, as well as key partnerships and financing benchmarks for the coming quarter. The webcast is a unique opportunity for current and potential investors to have direct access to HAVN Life's chief executive officer through an interactive question and anwer portal and find out more about the company and its milestones. Who: Mr. Moore, HAVN Life Sciences -- CEO When: Wednesday, March 3, at 2 p.m. EST An archived version of the webcast and presentation will be available on the investor relations section of the company's website. About HAVN Life Sciences Inc.
<< Previous
Bullboard Posts
Next >>